Serina Therapeutics
SER
28 hedge funds and large institutions have $2.66M invested in Serina Therapeutics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 4 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more ownership
Funds ownership: 0.36% → 0.36% (+0%)
0% less capital invested
Capital invested by funds: $2.67M → $2.66M (-$10.5K)
10% less funds holding
Funds holding: 31 → 28 (-3)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$31.4K |
| 2 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$10.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$8.07K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.78K |
| 5 |
SWIG
Strategic Wealth Investment Group
Louisville,
Kentucky
|
+$2.65K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$12K |
| 2 |
Millennium Management
New York
|
-$10K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$6K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$864 |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$148 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PP
26
Pacifica Partners
Surrey,
Canada
| $161 | – | – | – |
|
27
Bank of America
Charlotte,
North Carolina
| $123 | – | – | – |
|
|
LC
28
Lindbrook Capital
Calabasas,
California
| $95 | – | – | – |
|
|
CA
29
CoreCap Advisors
Southfield,
Michigan
| $6 | – | – | – |
|
|
VF
30
Virtu Financial
New York
| – | -$12K | -585 | Closed |
|
|
31
Millennium Management
New York
| – | -$10K | -492 | Closed |
|
|
32
Citadel Advisors
Miami,
Florida
| – | -$6K | -285 | Closed |
|
SER Hedge Fund Activity: Q4 2022 in Review
28 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q4 2022, worth a combined $2.66M — down 0.39% from $2.67M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of SER and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 7 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $31.4K. The largest seller was Virtu Financial, exiting entirely with an estimated $12K sold.
- 28 institutional investors held Serina Therapeutics (SER) as of Q4 2022, down from 31 in Q3 2022.
- Funds reported $2.66M of Serina Therapeutics stock for Q4 2022, down 0.39% quarter-over-quarter.
- 2 funds opened new Serina Therapeutics positions in Q4 2022 and 4 closed out, a net change of -2 holders.
- The largest Serina Therapeutics buyer in Q4 2022 was Susquehanna International Group, an estimated $31.4K added.
- The largest Serina Therapeutics seller in Q4 2022 was Virtu Financial, an estimated $12K sold.
Based on aggregated 13F filings for Q4 2022.